137 results on '"Janssen, Marcel J. R."'
Search Results
2. Theranostics in prostaatkanker
3. Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
4. Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery
5. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer
6. Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer
7. Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma
8. Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology
9. Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial
10. Prostaatspecifiek membraanantigeen radioligandtherapie met alfastralers, een review
11. Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
12. The diagnostic value of 18F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study
13. Tumoral Ki67 and PSMA Expression in Fresh Pre-PSMA-RLT Biopsies and Its Relation With PSMA-PET Imaging and Outcomes of PSMA-RLT in Patients With mCRPC
14. The Influence of Energy Depletion by Metformin or Hypocaloric Diet on Thyroid Iodine Uptake in Healthy Volunteers: a Randomized Trial
15. Tumoral Ki67 and PSMA Expression in Fresh Pre-PSMA-RLT Biopsies and Its Relation With PSMA-PET Imaging and Outcomes of PSMA-RLT in Patients With mCRPC.
16. PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study
17. Can late lymphoscintigraphy be omitted in the sentinel node procedure in early‐stage vulvar cancer?
18. Improving MRI‐based dosimetry for holmium‐166 transarterial radioembolization using a nonrigid image registration for voxelwise ΔR2∗$\Delta R_2^*$ calculation
19. Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer
20. Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
21. An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer
22. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise ΔR*2calculation.
23. PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.
24. Can late lymphoscintigraphy be omitted in the sentinel node procedure in early‐stage vulvar cancer?
25. Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres
26. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis
27. Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer
28. Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
29. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor
30. Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology
31. Tumor sink effect in 68Ga-PSMA-11 PET: Myth or Reality?
32. Tumor sink effect in 68Ga-PSMA-11 PET: Myth or Reality?.
33. PET imaging during hypoglycaemia to study adipose tissue metabolism
34. Reply to comment by Treglia and Bertagna: FDG PET/CT for detection of infectious endocarditis
35. Accuracy of 18F‐FDG PET/CT in predicting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer.
36. The diagnostic value of 18F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study
37. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by 18F-FDG Pharmacokinetics Using Dynamic PET/CT Scanning.
38. Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer.
39. The diagnostic value of 18F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis -- a prospective study.
40. 223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice.
41. Effect of Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 (UGT1A6) on Acetylsalicylic Acid Metabolism in Healthy Female Volunteers
42. 18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality.
43. Genetic Polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and Gastric Cancer Risk in a Vietnamese Population
44. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
45. SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0.
46. Multiparametric MRI and 18 F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.
47. Thoughts on "Tumor Sink Effect in 68 Ga-PSMA-11 PET: Myth or Reality?"
48. An Update to the Pilot Study of 177 Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer.
49. Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225 Ac-PSMA-617 targeted alpha-radiation therapy.
50. Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.